NuCare Pharmaceuticals has recalled various strengths of Valsartan/HCTZ (valsartan and hydrochlorothiazide) prescription tablets packaged in 30-count and 90-count jars. This recall was initiated because the active ingredient used to manufacture these blood pressure medications was found to contain a carcinogenic impurity. Consumers who have these medications should not stop taking them without first consulting their healthcare provider or pharmacist, as the risk of stopping the medication suddenly may be greater than the risk of the impurity.
The medication contains an active pharmaceutical ingredient that was found to have a carcinogen impurity, which is a substance that could potentially cause cancer with long-term exposure.
Guidance and refund for unused medication
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.